Article Figures & Data
Figures
- Figure 1.
Survival in treatment for MAT patients with integrated primary care vs. separate primary care. Abbreviation: MAT, Medication-assisted treatment.
Tables
- Table 1.
Predictors of Treatment Dropout in Gender-Adjusted Multivariate Time to Event Analysis
Variable Hazard Ratio 95% CI MAT integrated with primary care 0.49 0.33-0.72 Buprenorphine maintenance dose ≥ 22 mg daily 0.53 0.30-0.95 16 to 20 mg daily 0.52 0.29-0.94 10 to 14 mg daily 0.95 0.51-1.79 Participation in any behavioral health 0.69 0.46-1.03 Having an active diagnosis of depression 0.63 0.42-0.93 Having an active diagnosis of attention deficit disorder 0.7 0.46-1.04 Unprescribed amphetamine/methamphetamine use during MAT 1.69 1.13-2.53 Cocaine use during MAT 1.39 0.93-2.07 History of intravenous drug use before MAT 1.65 1.04-2.61 History of heroin use before MAT 1.11 0.65-1.89 MAT, Medication-assisted treatment; CI, confidence interval.
